These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

122 related items for PubMed ID: 38836447

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Newcastle disease virus vectored infectious laryngotracheitis vaccines protect commercial broiler chickens in the presence of maternally derived antibodies.
    Yu Q, Spatz S, Li Y, Yang J, Zhao W, Zhang Z, Wen G, Garcia M, Zsak L.
    Vaccine; 2017 Feb 01; 35(5):789-795. PubMed ID: 28052812
    [Abstract] [Full Text] [Related]

  • 3. Newcastle disease virus (NDV) recombinants expressing infectious laryngotracheitis virus (ILTV) glycoproteins gB and gD protect chickens against ILTV and NDV challenges.
    Zhao W, Spatz S, Zhang Z, Wen G, Garcia M, Zsak L, Yu Q.
    J Virol; 2014 Aug 01; 88(15):8397-406. PubMed ID: 24829337
    [Abstract] [Full Text] [Related]

  • 4. A recombinant Newcastle disease virus (NDV) expressing infectious laryngotracheitis virus (ILTV) surface glycoprotein D protects against highly virulent ILTV and NDV challenges in chickens.
    Kanabagatte Basavarajappa M, Kumar S, Khattar SK, Gebreluul GT, Paldurai A, Samal SK.
    Vaccine; 2014 Jun 12; 32(28):3555-63. PubMed ID: 24793943
    [Abstract] [Full Text] [Related]

  • 5. Glycoprotein-C-gene-deleted recombinant infectious laryngotracheitis virus expressing a genotype VII Newcastle disease virus fusion protein protects against virulent infectious laryngotracheitis virus and Newcastle disease virus.
    Wei X, Shao Y, Han Z, Sun J, Liu S.
    Vet Microbiol; 2020 Nov 12; 250():108835. PubMed ID: 33011664
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Current and future vaccines and vaccination strategies against infectious laryngotracheitis (ILT) respiratory disease of poultry.
    García M.
    Vet Microbiol; 2017 Jul 12; 206():157-162. PubMed ID: 28057380
    [Abstract] [Full Text] [Related]

  • 12. Long-term protection against a virulent field isolate of infectious laryngotracheitis virus induced by inactivated, recombinant, and modified live virus vaccines in commercial layers.
    Palomino-Tapia VA, Zavala G, Cheng S, García M.
    Avian Pathol; 2019 Jun 12; 48(3):209-220. PubMed ID: 30640536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Recombinant infectious laryngotracheitis virus expressing Newcastle disease virus F protein protects chickens against infectious laryngotracheitis virus and Newcastle disease virus challenge.
    Shao Y, Sun J, Han Z, Liu S.
    Vaccine; 2018 Dec 18; 36(52):7975-7986. PubMed ID: 30448332
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Maternal antibody inhibition of recombinant Newcastle disease virus vectored vaccine in a primary or booster avian influenza vaccination program of broiler chickens.
    Bertran K, Lee DH, Criado MF, Balzli CL, Killmaster LF, Kapczynski DR, Swayne DE.
    Vaccine; 2018 Oct 15; 36(43):6361-6372. PubMed ID: 30241684
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.